BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 36841437)

  • 21. Demographic trends and disease-specific survival in salivary acinic cell carcinoma: an analysis of 1129 cases.
    Patel NR; Sanghvi S; Khan MN; Husain Q; Baredes S; Eloy JA
    Laryngoscope; 2014 Jan; 124(1):172-8. PubMed ID: 23754708
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MUC4 is a valuable marker for distinguishing secretory carcinoma of the salivary glands from its mimics.
    Taverna C; Baněčková M; Lorenzon M; Palomba A; Franchi A; Skalova A; Agaimy A
    Histopathology; 2021 Sep; 79(3):315-324. PubMed ID: 32931030
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recurrent genetic alterations and biomarker expression in primary and metastatic squamous cell carcinomas of the vulva.
    Xing D; Liu Y; Park HJ; Baek I; Tran H; Cheang G; Novo J; Dillon J; Matoso A; Farmer E; Cheng MA; Tsai YC; Lombardo K; Conner MG; Vang R; Hung CF; Wu TC; Song W
    Hum Pathol; 2019 Oct; 92():67-80. PubMed ID: 31437519
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Integration of comprehensive genomic profiling, tumor mutational burden, and PD-L1 expression to identify novel biomarkers of immunotherapy in non-small cell lung cancer.
    Shi Y; Lei Y; Liu L; Zhang S; Wang W; Zhao J; Zhao S; Dong X; Yao M; Wang K; Zhou Q
    Cancer Med; 2021 Apr; 10(7):2216-2231. PubMed ID: 33655698
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mist1: a novel nuclear marker for acinic cell carcinoma of the salivary gland.
    Hsieh MS; Jeng YM; Lee YH
    Virchows Arch; 2019 Nov; 475(5):617-624. PubMed ID: 31187185
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnostic accuracy of pan-TRK immunohistochemistry in differentiating secretory carcinoma from acinic cell carcinoma of salivary gland-A systematic review.
    Sharma P; Sivakumar N; Pandiar D
    J Oral Pathol Med; 2023 Mar; 52(3):255-262. PubMed ID: 36207812
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Case-control analysis of survival outcomes in sinonasal acinic cell carcinoma.
    Biron VL; Lentsch EJ; Gerry DR; Bewley AF
    Int Forum Allergy Rhinol; 2014 Jun; 4(6):507-11. PubMed ID: 24599557
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heterotopic SMARCB1-deficient high-grade transformed/dedifferentiated acinic cell carcinoma and sine-qua-non radiology- pathology with TNM challenge.
    Maghami E; Afkhami M; Villaflor V; Bell D
    Ann Diagn Pathol; 2022 Apr; 57():151900. PubMed ID: 35077953
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential diagnosis and treatment of salivary secretory carcinoma and acinic cell carcinoma.
    Pang Y; Sun L; Liu H; Ma J
    Oral Oncol; 2021 Aug; 119():105370. PubMed ID: 34157553
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Utility of NR4A3 on FNA cytology smears and liquid-based preparations of salivary gland.
    Millan N; Tjendra Y; Zuo Y; Jorda M; Garcia-Buitrago M; Velez-Torres JM; Gomez-Fernandez C
    Cancer Cytopathol; 2022 Dec; 130(12):949-954. PubMed ID: 35913415
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acinic cell carcinoma with high-grade transformation: a report of 9 cases with immunohistochemical study and analysis of TP53 and HER-2/neu genes.
    Skálová A; Sima R; Vanecek T; Muller S; Korabecna M; Nemcova J; Elmberger G; Leivo I; Passador-Santos F; Walter J; Rousarova M; Jedlickova K; Curik R; Geierova M; Michal M
    Am J Surg Pathol; 2009 Aug; 33(8):1137-45. PubMed ID: 19461506
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The HTN3-MSANTD3 Fusion Gene Defines a Subset of Acinic Cell Carcinoma of the Salivary Gland.
    Andreasen S; Varma S; Barasch N; Thompson LDR; Miettinen M; Rooper L; Stelow EB; Agander TK; Seethala RR; Chiosea SI; Homøe P; Wessel I; Larsen SR; Erentaite D; Bishop JA; Ulhøi BP; Kiss K; Melchior LC; Pollack JR; West RB
    Am J Surg Pathol; 2019 Apr; 43(4):489-496. PubMed ID: 30520817
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical and pathologic prognostic features in acinic cell carcinoma of the parotid gland.
    Gomez DR; Katabi N; Zhung J; Wolden SL; Zelefsky MJ; Kraus DH; Shah JP; Wong RJ; Ghossein RA; Lee NY
    Cancer; 2009 May; 115(10):2128-37. PubMed ID: 19309749
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ultrastructural Characterization of Mammary Analogue Secretory Carcinoma of the Salivary Glands: A Distinct Entity from Acinic Cell Carcinoma?
    Guilmette J; Nielsen GP; Faquin WC; Selig M; Nosé V; Chi AWS; Sadow PM
    Head Neck Pathol; 2017 Dec; 11(4):419-426. PubMed ID: 28194567
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of CDKN2A/B mutations, PD-1, and PD-L1 with the risk of acute lymphoblastic leukemia in children.
    Ruan Y; Xie L; Zou A
    J Cancer Res Clin Oncol; 2023 Sep; 149(12):10841-10850. PubMed ID: 37314514
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Papillary-cystic pattern is characteristic in mammary analogue secretory carcinomas but is rarely observed in acinic cell carcinomas of the salivary gland.
    Hsieh MS; Chou YH; Yeh SJ; Chang YL
    Virchows Arch; 2015 Aug; 467(2):145-53. PubMed ID: 25976476
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acinic cell carcinoma of the oral and maxillofacial region: an international multicenter study.
    Kirschnick LB; Silveira FM; Schuch LF; Vasconcelos ACU; Gomes AP; Santos JND; Santana DA; Fonseca FP; Mesquita RA; Mendonça EF; Sousa-Neto SS; Pontes HAR; Robinson L; Heerden WV; Carlos-Bregni R; Tager EMJR; Silva LCD; Zanella VG; Rivero LF; Bittencourt R; Martins MAT; Lopes MA; Wagner VP; Vargas PA; Martins MD
    Braz Oral Res; 2023; 37():e050. PubMed ID: 37255070
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acinic Cell Carcinoma in the 21st Century: A Population-Based Study from the SEER Database and Review of Recent Molecular Genetic Advances.
    Khan J; Ullah A; Goodbee M; Lee KT; Yasinzai AQK; Lewis JS; Mesa H
    Cancers (Basel); 2023 Jun; 15(13):. PubMed ID: 37444484
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlation of MTAP Immunohistochemistry With CDKN2A Status Assessed by Fluorescence In Situ Hybridization and Clinicopathological Features in CNS WHO Grade 2 and 3 Meningiomas: A Single Center Cohort Study.
    Sasaki S; Takeda M; Hirose T; Fujii T; Itami H; Uchiyama T; Morita K; Matsuda R; Yamada S; Nakagawa I; Ohbayashi C
    J Neuropathol Exp Neurol; 2022 Jan; 81(2):117-126. PubMed ID: 34897475
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Salivary Gland Secretory Carcinoma: Clinicopathologic and Genetic Characteristics of 215 Cases and Proposal for a Grading System.
    Baněčková M; Thompson LDR; Hyrcza MD; Vaněček T; Agaimy A; Laco J; Simpson RHW; Di Palma S; Stevens TM; Brcic L; Etebarian A; Dimnik K; Majewska H; Stárek I; O'Regan E; Salviato T; Helliwell T; Horáková M; Biernat W; Onyuma T; Michal M; Leivo I; Skalova A
    Am J Surg Pathol; 2023 Jun; 47(6):661-677. PubMed ID: 37070739
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.